USPTO 2015–2025 USPTO PatentsView US Corporation

Arcadia Biosciences, Inc.

USPTO PatentsView assignee record - 27 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A01H (NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques).

RSS updates for this company

The verdict

According to USPTO PatentsView, Arcadia ranks #11,167 of 49,997 tracked US assignees by granted-patent volume, with 27 patents across 8 technology areas.

#11,167
of 49,997 US assignees by volume
45th percentile
by Innovation Score (33.8/100)
15.3
avg claims per patent
+27%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11167 · US Corporation #11,167 · 27 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

  • GRANTS-SMALL 27 grants
  • UPPER-Q #11,167/49,997
  • PHOTO-FINISH Adaptimmune
  • CPC-NARROW A01H · 8 areas
  • INNOV-THIN 33.8/100
  • CLAIMS-RICH 15.3 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-UP +27% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Adaptimmune Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Arcadia’s 33.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Arcadia

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Arcadia's Innovation Score is 33.8/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Arcadia?

Each dot is one of Arcadia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Arcadia’s own 15.3 claims/patent is ABOVE the 14.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Arcadia vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 26.92727.1 510152025 Granted patents (volume) Avg claims / patent Alfmeier PRÄZISION SE - 27, 14.81Alfmeier PRÄZisio…Anagog Ltd. - 27, 22.15AnagogAngus Chemical Company - 27, 15.78Angus ChemicalApollo Education Group, Inc. - 27, 21.74Apollo Education…Asahi Group Holdings, Ltd. - 27, 8.81Asahi Group Holdi…Assa Abloy Residential Group, Inc. - 27, 10.04Assa Abloy Reside…Adaptimmune Limited - 27, 13.26AdaptimmuneAddepar, Inc. - 27, 17.44AddeparArcadia Biosciences, Inc. - 27, 15.3Arcadia Bioscienc…
Arcadia vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Arcadia's grants concentrate

Arcadia Biosciences, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under A01H (NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques). Peak complete grant year is 2019 (5 grants) versus a trough of 1 in 2018. By volume, Arcadia sits between Alfmeier PRÄZISION SE and Addepar, Inc..

Arcadia's three-year grant acceleration

Arcadia Biosciences, Inc. shows 6 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Arcadia's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Arcadia holds 27 patents at rank #11,155, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Arcadia

By rank, the assignees closest to #11,155 in granted patent volume.

Leaders in A01H (NEW Plants OR)

Other assignees with the most granted patents in Arcadia's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Arcadia, neither rank-band nor same-CPC leaders (those blocks stay above). In A01H (NEW Plants OR), Arcadia ranks #29 of 285 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (34 here).

Arcadia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 45th percentile higher than 45% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 2015201620182019202020212022202320242025 2
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Arcadia Biosciences, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 7.4%
2016 3 11.1%
2018 1 3.7%
2019 5 18.5%
2020 5 18.5%
2021 3 11.1%
2022 1 3.7%
2023 3 11.1%
2024 2 7.4%
2025partial year 2 7.4%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Arcadia Biosciences, Inc.'s patent record in context - here's where to go next.

  • Arcadia Biosciences, Inc.'s lead technology class is A01H (NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques), 100% of its portfolio - see every assignee active in that class. Explore A01H
  • Ranked #11,167 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Arcadia Biosciences, Inc. against Alfmeier PRÄZISION SE, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 33.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.